Legal Drugs Podcast cover art

Legal Drugs Podcast

Legal Drugs Podcast

Written by: Angela Stoyanovitch
Listen for free

About this listen

 Every day, each of us is affected by legal drugs. The pharmaceutical industry is one of the strongest, richest and yet most mysterious industries in America. Why do some drugs make it to market and others don't? Why are some drugs so expensive? And what is the human effect of this industry? Join industry veteran Angela Stoyanovitch as she explores the complex systems in place and what it means for you and me.All material copyright Legal Drugs Agency 2019 Hygiene & Healthy Living Physical Illness & Disease Politics & Government
Episodes
  • 33. Investigating Cardiotoxicity in a 3-Drug Comparison for the Treatment of COVID19 with AnaBios's Dr. Najah Abi-Gerges

    33. Investigating Cardiotoxicity in a 3-Drug Comparison for the Treatment of COVID19 with AnaBios's Dr. Najah Abi-Gerges
    Jul 19 2021

    In this episode, Legal Drugs Podcast Host, Angela Stoyanovitch, speaks with Dr. Najah Abi-Gerges, head of AnaBios Corporation's R&D. Najah walks the audience through recent publications in collaboration with big pharma on the cardiotoxicity effects of three drugs that have been posed to treat COVID19. Cardiotoxicity studies are an important step in understanding the safety of a legal drug. AnaBios uses their early-stage discovery and translational research model to test and compare Hydroxychloroquine, Chloroquine and Azithromycin in adult human primary cardiomyocytes. Cardio safety is especially personal to both Angela and Najah as both speak about their family history with heart disease. More importantly, for areas and parts of the world where COVID vaccines will not be made available or accessible, viable treatments need to be accessed for potential risks in order to provide the best alternatives.

    Link to Scientific Report article, NIH & FDA press releases from AnaBios;

    NIH/NCATS Awards SBIR Grant to AnaBios

    FDA Inks Research Collaboration with AnaBios

    FDA Awards AnaBios Contract

    This episode edited and produced by Margaret Beveridge.
    Show More Show Less
    33 mins
  • 32. How Legal Drugs are Making History Faster Than Ever Before & Why Legal Drugs Agency Cares by Angela Stoyanovitch

    32. How Legal Drugs are Making History Faster Than Ever Before & Why Legal Drugs Agency Cares by Angela Stoyanovitch
    Nov 17 2020
    Over the month of October 2020, Legal Drugs Podcast (LDP), a production of Legal Drugs Agency, LLC (LDA), was on a strategic sabbatical to give back and reorganize. In this episode, Host, Angela Stoyanovitch, recaps the lasted COVID cure announcements with new drugs announced from both Pfizer and Moderna (biotech and pharma companies.) Unusually, their announcements included 90-95% efficacy of the vaccines which were developed at record speeds. While drugs of any kind have had longer development periods in the past, Legal Drugs Podcast has continually highlighted that the increased speeds can be attributed to many variables - the most obvious is the use of technology, machine learning and A.I. for early drug discovery. To the general public who is outside of the drug development industry, this all may seem mysterious and confusing but we explain that this is a manifestation of the use of creative scientific theory and understanding of DNA, etc. No longer will we rely on simple chemical compounding for drugs. The future of legal drugs is curative drugs and we are in a space race within the biotech industry to find them! This is an exciting time in history to be a witness to such speedy developments and with a global threat such as the COVID-19 pandemic, the pressure (and funding) are on high! Together, we will continue to discuss these advancements in bite side portions as we have in the first 31 episodes of the show, Legal Drugs Podcast. As Angela outlines in this episode, 32, we are looking to the future for more gene editing that will result in more gene and cell therapies. This Spring 2021, Legal Drugs Agency will produce a new livestream salon-styled intimate conference on gene therapies via LDA partner, PharmaSalon. If you know someone you'd like to recommend as a speaker, please reach out to our host, angela@legaldrugsagency.com. If you are in the market for a career change within the life sciences industry, specifically, the drug development and contract research organization niche, Angela would love to introduce you to our LDA partner, RPM ReSearch Solutions, for career coaching, resources and matching to open candidate roles. This Fall 2020, we are launching our YouTube channel as a result of our efforts over the last month. Stay tuned for more information and subscribe now @legaldrugspodcast on YouTube and Instagram to stay up to date on our announcements. Thank you to those who have supported LDP as a patron on www.patreon.com/legaldrugspodcast. Your support means the world to us and we wouldn't be here without your generous contributions that help us create more content. Thank you! Other sabbatical work includes two recordings with Angela on Lab Rat Chat, an interview with their podcast hosts where Angela dives deep into her career and life story - listen here for free; Chat with Legal Drugs Podcast on Lab Rat Chat Podcast - and a podcast panel discussion recording as a platform session for the National Annual Meeting for the American Association for Laboratory Animal Science (AALAS) - read more on page 26 of the virtual program; NAALAS Panel Discussion: Podcasting to the Public. Finally, LDA was established with the idea that we highlight the heartbeat of biomedical research and the drug development continuum. What do we do this work? Why do we study new drugs and how do we give back? No matter how you slice it, legal drugs has an impact on all of us. For those of us deep in our drug development work or corporate lives, it is easy to lose touch with that heartbeat or the stories of people's lives we impact one way or another. This is the legal drugs business we discuss here but what about the illegal drug business on the streets affecting people in great need due to addictions and mental illness. We all can have a positive impact (great or small) on each other's mental and emotional health. As Host Angela has a great passion for groups of both animals and women in need, she often volunteers for these various causes. While on sabbatical these last 4-6 weeks, Angela describes a new event she hosted to raise hygiene donations for women on the streets. This fundraising event was called Girls Giving and it resulting in over $300 of tampons and sanitary napkins that will be distributed by Restore Global as organized by iServewithJoy nonprofits in the metro-Charlotte, NC area. Thank you for listening, downloading and reviewing our episodes. Check out our new landing page at www.podpage.com/site/legal-drugs-podcast for more episodes!
    Show More Show Less
    24 mins
  • 31. Mitigating Animal Research Policy for the Cause of Biomedical & Scientific Progress with Tom Leach of Leach Policy Management, LLC

    31. Mitigating Animal Research Policy for the Cause of Biomedical & Scientific Progress with Tom Leach of Leach Policy Management, LLC
    Sep 21 2020

    In this episode of Legal Drugs Podcast, Host (NEW landing page www.podpage.com/site/legal-drugs-podcast), Angela Stoyanovitch, interviews Tom Leach, Esq. Tom is the executive director of the New Jersey Association for Biomedical Research (NJABR) and the Pennsylvania Society for Biomedical Research (PSBR). In addition to biomedical research advocacy, Tom monitors legal and legislative develops related to animal welfare in New Jersey and across the country. Tom has extensive experience developing policy positions and legislative initiatives for association management and government affairs clients. Tom has more than fifteen years of experience working in state government and legal affairs. Tom began his career as an aide to New Jersey Governors Whitman and DiFrancesco in the Office of Constituent Relations and later served as a legislative aide to a New Jersey State Senator. Previously, Tom served as counsel to a large real estate brokerage firm. Tom received a BA in Political Science from the College of New Jersey and a JD from Seton Hall.

    To learn more about the programs mentioned on the show, to go www.psbr.org, www.njabr.org and www.sparcscience.com (PSBR's education program.)

    If you are planning to attend the National American Association for Laboratory Animal Science (AALAS) this November, 2020, look for our session now published in the preliminary program for a panel discussion organized by Legal Drugs Agency, LLC (LDA) titled, "Podcasting to the Public and the Art of Storytelling" where panelists including Angela Stoyanovitch and Tom Leach will discuss the ins-and-outs of podcasting as a digital platform for laboratory animal science professionals for public insight. Sponsors of this discussion include Legal Drugs Agency, LLC. Additional resources can be found here; https://www.aalas.org/national-meeting/general-information/meeting-program and https://issuu.com/aalasoffice/docs/2020_charlotte_preliminary_program_final.

    If you'd like to become a patron of Legal Drugs Podcast, please log on to www.patreon.com/legaldrugspodcastto support us today. We appreciate your patronage in advance.

    This episode edited and produced by Margaret Beveridge.
    Show More Show Less
    51 mins
No reviews yet